Incidences of adverse effects of medical treatment are on the rise globally. In 2017, around 121.5 deaths were registered as a result of adverse medical effect. Also, based on a study conducted by the U.S-based John Hopkins University in 2016, medical errors are the third leading cause of deaths in the U.S. Other severe effects of medical treatment that have been recorded are significant permanent injury, brain damage, and lifelong care. Further, based on the data collated by the Institute of Health Metrics and Evaluation in the U.S., China recorded the maximum number of deaths due to adverse effects of medical treatment in 2016 and 2017.
Rising incidence of colorectal cancer, neurological disorders, interventional cardiology disorders, and gynaecological diseases, growing geriatric population have helped in the establishment of the surgical robotics market, and has garnered active participation of the government and the industry players for the adoption of surgical robotics, which in turn have boosted the overall growth of the market. According to the market intelligence report by BIS Research titled, ’Global Surgical Robotics Market- Analysis and Forecast (2017-2025)’, the market is anticipated to reach $12.60 billion by the year 2025, registering a CAGR of 11.4% during the forecast period 2017-2025. This tremendous growth is attributed to the rising demands of minimally invasive surgeries, increasing rate of chronic diseases, general awareness regarding computer aided surgeries, rising disposable income, and introduction of technologically advanced systems, such as SurgiBot, Modus V, and Single Port Orifice Robotic Technology (SPORT), among others.